Tag: Placenta

Available data from case reports and observational studies suggest that the biologic drug Dupixent (dupilumab) is probably safe during pregnancy for conditions like atopic dermatitis and asthma, although it is known to cross the placenta. Deciding to use Dupixent while pregnant requires a careful, shared discussion with a healthcare provider, weighing the potential risks against the benefits of treating the underlying condition.

Almost all pregnant women will take at least one medication during pregnancy. Understanding which medications do not cross the placenta is crucial for ensuring fetal safety while effectively managing maternal health conditions, and it is a topic of significant importance in maternal-fetal medicine.